Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.

ABSTRACT:

SUBMITTER: Ferrua F 

PROVIDER: S-EPMC6494976 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature